Understanding Bone Complications From Metastases
As advanced prostate cancer progresses it becomes inevitable that we will develop bone metastases. The treatments available are designed to slow disease progression, to relieve pain and to avoid the complications that result from bones [...]
Keep Our Club Exclusive
U.S. News and World Review, in their HealthDay section reported an interesting aspect of the continuing debate about treatment vs. “watchful waiting” (active surveillance). The article, written by Karen Pallarito “Rethinking Prostate Cancer in Older [...]
Lets Get Our Descriptors To Agree With Reality
The number of men with Hormone Refractory Prostate Cancer (HRCP) is ever increasing; some statisticians feel that it could eventually become the most common cancer in the male population. The clinical variability, the lack of [...]
The benefits of Short Term Bisphosphonate Therapy
According to data published in the Journal of Clinical Oncology (2008; 26:4426-34), once a week, bisphosphonate therapy improves bone density and improves turnover in prostate cancer patients with nonmetastatic disease who are on androgen deprivation [...]
From the New York Times, The Scan That Didn’t Scan
In today’s New York Times Gina Kolata wrote a very interesting article about the unreliability of MRIs for diagnostic purposes. She wrote from the perspective of orthopedic injuries, but since MRIs are main stays for [...]
Issues Surrounding Long Term Bisphosphonate Therapy
On the advanced prostate cancer group I moderate there has been a discussion about the health risks of using Fosamax for an extended period of time. The risks of long term therapy remains unclear and [...]